@article{6ac14cea8f214f7c961db5104a6e2a76,
title = "Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017",
abstract = "The 2nd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 03-05 November 2017 in Detroit, Michigan, USA. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF Inc.) founded in the USA, and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This was the second annual meeting of the SHSA with experts from different disciplines arriving from North America, Europe and Australia, in a joint aim to discuss most recent innovations, practical challenges and potential solutions to issues related in the management and care of Hidradenitis Suppurativa patients. The last session involved clinicians, patients and their families in an effort to educate them more about the disease.",
keywords = "hidradenitis suppurativa, symposium",
author = "Eran Shavit and Afsaneh Alavi and Bechara, {Falk G.} and Bennett, {Richard G.} and Marc Bourcier and Ricardo Cibotti and Steven Daveluy and Frew, {John W.} and Amit Garg and Iltefat Hamzavi and Hoffman, {Lauren K.} and Jenny Hsaio and Kirby, {Joslyn Sciacca} and Hadar Lev-Tov and Erin Martinez and Robert Micheletti and Naik, {Haley B.} and Aude Nassif and Cynthia Nicholson and Angie Parks-Miller and Zarine Patel and Vincent Piguet and Mayur Ramesh and Barry Resnik and Christopher Sayed and Gregory Schultz and Aamir Siddiqui and Jerry Tan and Ximena Wortsman and Lowes, {Michelle A.}",
note = "Funding Information: AA has received consulting fees from AbbVie, Actelion, Celgene, Galderma, GSK, InflaRx, Janssen, Kyowa Incyte Leo Pharma Novartis Pfizer Regeneron Roche Sanofi2 Genzyme UCB Valeant. FGB has received consulting fees from AbbVie. He is on the advisory Board for AbbVie, Janssen, and is an investigator for AbbVie, Janssen, Novartis and InflaRx. RGB has no conflicts of interest. MB is a Speaker for Astellas, AbbVie, Amgen, Eli-Lilly, La Roche-Posay, LEO Pharma, Janssen, Novartis, Pfizer, Merck, Valeant. He is on the Advisory Board for AbbVie, Amgen, Bausch Health, Eli-Lilly, La Roche-Posay, LEO Pharma, Janssen, Novartis, Pfizer, Merck, Valeant, and he is also an investigator of clinical trials for AbbVie, Amgen, Astellas, Basilea, Biogen, Celgene, Eli-Lilly, Galderma, Janssen, Johnson & Johnson, Janssen, Merck, Novartis, Ortho Biotech, Pfizer. RC has no conflicts of interest. SD is the speaker for AbbVie, and an investigator for Regeneron and InflaRx. JF has no conflicts of interest. AG has received consulting fees from AbbVie, Asana Biosciences, Janssen, Pfizer, UCB; grant support from AbbVie, UCB, National Psoriasis Foundation.IHH is the President of the HS Foundation, in a non-compensated role, an Investigator for; Lenicura (equipment received, no grant), AbbVie (grant paid to institution), Jansen (grant paid to institution), is or has been a consultant with fees received by UCB, Novartis, Incyte, Pfizer. LKH has no conflicts of interest. JH has no conflicts of interest. JSK is a speaker for AbbVie and has received consulting fees from Incyte and ChemoCentryx.HLT is the founder of Dermveda, Inc. and is an investigator for Factor Therapeutics, Molnlycke, BSN, TissuTech, Ilkos and Medline. EM has no conflicts of interest. RM has no conflicts of interest. MAL has received consulting fees from AbbVie, Xbiotech, Janssen, BSN: consultant/ Ad boards, and consultant on clinical trial for Incyte. HBN has received a research grant from Abbvie. AN has received travel grant from AbbVie, MSD. CN has no conflicts of interest. APM is a consultant for non-marketing materials for AbbVie and has received fees, serves or has served on an Advisory Board for AbbVie and has received fees, and serves or has served as a consultant for BSN and has received fees, is the President & Founding Director of Hope for HS in a non-compensated role and is an employee of the HS Foundation. ZP has no conflicts of interest. VP reports receiving educational grants from Abbvie, Celgene, Janssen, Naos, Lilly, Sanofi, Valeant, and nonfinancial support from La Roche-Posay. VP undertakes personal advisory work with Pfizer, AbbVie, Janssen, UCB, Novartis, Almirall and Celgene. MR has no conflicts of interest. BR has no conflicts of interest. CS is the speaker for Abbvie Inc. and for Norvartis, an investigator for UCB, and serves both as an investigator and consultant for InflaRx. GS in the last 12 months has been a consultant for Medline and has received research grants from Medline, B Braun, Next Science, Avadim, and Smith & Nephew. ES has no conflicts of interest. AS in the last",
year = "2019",
month = jan,
doi = "10.1111/exd.13849",
language = "English (US)",
volume = "28",
pages = "94--103",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "1",
}